Is there any real reason a far sighted Pharma couldn’t do a deal with PAR prior to 2x2 dose validation.
Cant they just do the deal on the proviso 2x2 gets approved with a walk away clause if 2x2 dose not approved by the FDA etc.
Is there any real reason a far sighted Pharma couldn’t do a deal...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
0.005(2.08%) |
Mkt cap ! $85.73M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 25.0¢ | 23.0¢ | $180.4K | 746.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 79748 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 36818 | 5 |
View Market Depth
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |